177 related articles for article (PubMed ID: 22998193)
1. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.
Soucie JM; De Staercke C; Monahan PE; Recht M; Chitlur MB; Gruppo R; Hooper WC; Kessler C; Kulkarni R; Manco-Johnson MJ; Powell J; Pyle M; Riske B; Sabio H; Trimble S;
Transfusion; 2013 Jun; 53(6):1217-25. PubMed ID: 22998193
[TBL] [Abstract][Full Text] [Related]
2. Absence of evidence of parvovirus B19 transmission by plasma-derived clotting concentrates derived from B19V nucleic acid technology-tested plasma and including effective steps for the inactivation or removal of nonenveloped viruses.
Gajardo R; Roth NJ; Lee DC; Jorquera JI
Transfusion; 2013 May; 53(5):1141-2. PubMed ID: 23659531
[No Abstract] [Full Text] [Related]
3. Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates.
Soucie JM; Monahan PE; Kulkarni R; De Staercke C; Recht M; Chitlur MB; Gruppo R; Hooper WC; Kessler C; Manco-Johnson MJ; Powell J; Pyle M; Riske B; Sabio H; Trimble S
Transfusion; 2013 May; 53(5):1143-4. PubMed ID: 23659532
[No Abstract] [Full Text] [Related]
4. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
6. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.
Soucie JM; Siwak EB; Hooper WC; Evatt BL; Hollinger FB;
Transfusion; 2004 Aug; 44(8):1179-85. PubMed ID: 15265122
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.
Sun P; Jiang P; Liu Q; Zhang R; Wang Z; Cao H; Ye X; Ji S; Han J; Lu K; He X; Fan J; Cao D; Zhang Y; Yin Y; Chen Y; Zhao X; Ye S; Su N; Du X; Ma L; Li C
PeerJ; 2023; 11():e15698. PubMed ID: 37554334
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 transmission by heat-treated clotting factor concentrates.
Blümel J; Schmidt I; Effenberger W; Seitz H; Willkommen H; Brackmann HH; Löwer J; Eis-Hübinger AM
Transfusion; 2002 Nov; 42(11):1473-81. PubMed ID: 12421221
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
Abdelrahman D; Al-Sadeq DW; Smatti MK; Taleb SA; AbuOdeh RO; Al-Absi ES; Al-Thani AA; Coyle PV; Al-Dewik N; Qahtani AAA; Yassine HM; Nasrallah GK
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805034
[TBL] [Abstract][Full Text] [Related]
13. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
[TBL] [Abstract][Full Text] [Related]
14. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes.
Jia J; Ma Y; Zhao X; Huangfu C; Zhong Y; Fang C; Fan R; Lv M; Zhang J
Virol J; 2016 Sep; 13(1):155. PubMed ID: 27639978
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa.
Rubinstein R; Karabus CD; Smuts H; Kolia F; Van Rensburg EJ
Haemophilia; 2000 Mar; 6(2):93-7. PubMed ID: 10781195
[TBL] [Abstract][Full Text] [Related]
16. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England.
Williams S; Ratcliff J; Nguyen D; Simmonds P; Harvala H;
Transfus Med; 2022 Oct; 32(5):402-409. PubMed ID: 35751630
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.
Faddy HM; Gorman EC; Hoad VC; Frentiu FD; Tozer S; Flower RLP
BMC Infect Dis; 2018 Dec; 18(1):631. PubMed ID: 30526514
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
20. Studies on the inactivation of human parvovirus 4.
Baylis SA; Tuke PW; Miyagawa E; Blümel J
Transfusion; 2013 Oct; 53(10 Pt 2):2585-92. PubMed ID: 24032592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
